Your browser is no longer supported. Please, upgrade your browser.
Adial Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.86 Insider Own5.40% Shs Outstand14.38M Perf Week9.05%
Market Cap34.49M Forward P/E- EPS next Y-0.59 Insider Trans-15.57% Shs Float11.64M Perf Month4.57%
Income-10.90M PEG- EPS next Q- Inst Own8.80% Short Float5.68% Perf Quarter-28.21%
Sales- P/S- EPS this Y-0.20% Inst Trans5.16% Short Ratio1.73 Perf Half Y15.08%
Book/sh0.28 P/B8.18 EPS next Y7.80% ROA-149.80% Target Price- Perf Year68.38%
Cash/sh0.29 P/C7.84 EPS next 5Y- ROE-171.40% 52W Range1.14 - 4.00 Perf YTD34.71%
Dividend- P/FCF- EPS past 5Y-47.50% ROI- 52W High-41.50% Beta-
Dividend %- Quick Ratio3.40 Sales past 5Y- Gross Margin- 52W Low105.26% ATR0.17
Employees8 Current Ratio3.40 Sales Q/Q- Oper. Margin- RSI (14)55.89 Volatility10.29% 8.09%
OptionableNo Debt/Eq0.00 EPS Q/Q-24.40% Profit Margin- Rel Volume0.36 Prev Close2.29
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume381.14K Price2.34
Recom2.00 SMA207.83% SMA501.75% SMA20015.81% Volume93,223 Change2.18%
Oct-30-18Initiated Maxim Group Buy $5
Oct-11-18Initiated Dawson James Buy
May-18-21 01:19PM  
Apr-07-21 11:09AM  
Mar-23-21 09:00AM  
Mar-17-21 10:00AM  
Mar-15-21 09:30AM  
Feb-26-21 03:05PM  
Feb-25-21 09:30AM  
Feb-23-21 01:00PM  
Jan-26-21 10:15AM  
Jan-11-21 11:00AM  
Dec-17-20 09:45AM  
Dec-15-20 09:30AM  
Dec-10-20 12:10PM  
Dec-09-20 11:25AM  
Dec-04-20 09:30AM  
Nov-25-20 12:20PM  
Nov-16-20 05:33AM  
Nov-03-20 09:50AM  
Oct-22-20 09:30AM  
Oct-21-20 09:30AM  
Sep-30-20 09:25AM  
Sep-29-20 09:30AM  
Sep-25-20 10:00AM  
Sep-22-20 09:30AM  
Sep-09-20 09:00AM  
Sep-01-20 07:22PM  
Aug-31-20 05:00PM  
Aug-06-20 09:30AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-22-20 09:45AM  
Jul-06-20 08:15AM  
Jun-25-20 09:30AM  
Jun-17-20 09:55AM  
Jun-15-20 09:30AM  
Jun-11-20 11:35AM  
Jun-10-20 10:06AM  
Jun-09-20 09:15AM  
Jun-08-20 09:30AM  
May-28-20 09:30AM  
May-04-20 10:15AM  
Apr-23-20 08:45AM  
Apr-16-20 10:17AM  
Apr-15-20 09:45AM  
Apr-09-20 09:30AM  
Mar-29-20 08:19AM  
Mar-26-20 09:15AM  
Mar-17-20 09:30AM  
Feb-19-20 09:37AM  
Feb-14-20 09:15AM  
Feb-06-20 12:30PM  
Jan-09-20 09:15AM  
Dec-30-19 05:36AM  
Dec-19-19 09:30AM  
Dec-16-19 09:00AM  
Dec-13-19 09:30AM  
Oct-29-19 08:30AM  
Oct-17-19 10:30AM  
Oct-07-19 09:26AM  
Oct-01-19 08:30AM  
Sep-27-19 11:52AM  
Sep-25-19 09:50AM  
Sep-11-19 09:15AM  
Sep-07-19 09:30AM  
Aug-06-19 04:30PM  
Jul-29-19 03:01PM  
Jun-19-19 09:00AM  
Jun-13-19 09:35AM  
Jun-06-19 09:00AM  
May-07-19 09:00AM  
Apr-30-19 09:00AM  
Apr-29-19 11:56AM  
Apr-22-19 09:00AM  
Apr-11-19 09:00AM  
Apr-04-19 09:00AM  
Apr-03-19 09:00AM  
Mar-26-19 09:00AM  
Mar-25-19 08:00AM  
Feb-28-19 03:02PM  
Feb-26-19 08:00AM  
Feb-21-19 01:35PM  
Feb-20-19 09:00AM  
Feb-15-19 08:30AM  
Feb-12-19 09:33AM  
Feb-07-19 09:15AM  
Feb-01-19 09:20AM  
Jan-24-19 08:30AM  
Jan-23-19 01:57PM  
Jan-17-19 09:00AM  
Jan-15-19 09:05AM  
Jan-10-19 08:00AM  
Dec-27-18 10:25AM  
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Bankole A.Chief Medical OfficerApr 06Sale2.50150,000375,000548,336Apr 08 09:47 PM
Johnson Bankole A.Chief Medical OfficerAug 20Sale1.21350,000423,5001,055Aug 24 04:59 PM